Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin Dropping Pills in Acute ST-Segment Elevation Myocardial Infarction
ChiCTR2400080728Phase 4Not yet recruiting
- Sponsor
- Ninghai First Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Shexiang Tongxin Dropping Pills in myocardial infarction (MI) (2 arms), sponsored by Ninghai First Hospital. Primary endpoints: Arrhythmia, Heart function and 2 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2400080728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080728.